Lack of negative impact of Philadelphia chromosome in older patients with acute lymphoblastic leukaemia in the thyrosine kinase inhibitor era: comparison of two prospective parallel protocols

Jonathan I. Sive, Georgina Buck, Adele Fielding, Hillard M. Lazarus, Mark R. Litzow, Selina Luger, David I. Marks, Andrew McMillan, Anthony V. Moorman, Susan M. Richards, Jacob M. Rowe, Martin S. Tallman, Anthony H. Goldstone, Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial British Journal of Haematology. ,vol. 157, pp. 463- 471 ,(2012) , 10.1111/J.1365-2141.2012.09095.X

Robin Foà, Antonella Vitale, Marco Vignetti, Giovanna Meloni, Anna Guarini, Maria Stefania De Propris, Loredana Elia, Francesca Paoloni, Paola Fazi, Giuseppe Cimino, Francesco Nobile, Felicetto Ferrara, Carlo Castagnola, Simona Sica, Pietro Leoni, Eliana Zuffa, Claudio Fozza, Mario Luppi, Anna Candoni, Ilaria Iacobucci, Simona Soverini, Franco Mandelli, Giovanni Martinelli, Michele Baccarani, , Dasatinib as first-line treatment for adult patients with Philadelphia chromosome–positive acute lymphoblastic leukemia Blood. ,vol. 118, pp. 6521- 6528 ,(2011) , 10.1182/BLOOD-2011-05-351403

Marco Vignetti, Paola Fazi, Giuseppe Cimino, Giovanni Martinelli, Francesco Di Raimondo, Felicetto Ferrara, Giovanna Meloni, Achille Ambrosetti, Giovanni Quarta, Livio Pagano, Giovanna Rege-Cambrin, Loredana Elia, Raffaello Bertieri, Luciana Annino, Robin Foà, Michele Baccarani, Franco Mandelli, Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome-positive patients with acute lymphoblastic leukemia without additional chemotherapy: results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocol Blood. ,vol. 109, pp. 3676- 3678 ,(2007) , 10.1182/BLOOD-2006-10-052746

Oliver G. Ottmann, Barbara Wassmann, Heike Pfeifer, Aristoteles Giagounidis, Matthias Stelljes, Ulrich Dührsen, Marc Schmalzing, Lydia Wunderle, Anja Binckebanck, Dieter Hoelzer, , Imatinib compared with chemotherapy as front-line treatment of elderly patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL). Cancer. ,vol. 109, pp. 2068- 2076 ,(2007) , 10.1002/CNCR.22631

Nicola Goekbuget, Thibaut Leguay, Mathilde Hunault, Chadi Al-Nawakil, Patrice Chevallier, Herve Dombret, Gisela Fritsch, Albert Oriol, Josep Maria Ribera, Philippe Rousselot, Juan Manuel Sancho, Dieter Hoelzer, First European Chemotherapy Schedule for Elderly Patients with Acute Lymphoblastic Leukemia: Promising Remission Rate and Feasible Moderate Dose Intensity Consolidation Blood. ,vol. 112, pp. 304- 304 ,(2008) , 10.1182/BLOOD.V112.11.304.304

Philippe Rousselot, Jean Michel Cayuela, Sandrine Hayette, Christian Récher, Thibaut Leguay, Celia Salanoubat, Francis Witz, Magda Alexis, Mathilde Hunault, Maud Janvier, Philippe Agape, Christian Berthou, Eric Jourdan, José Fernandes, Laurent Sutton, Anne Banos, Oumedaly Reman, Bruno Lioure, Xavier Thomas, Norbert Ifrah, Nicola Gokbuget, Dieter Hoelzer, Andre Delannoy, Renato Bassan, Jose M. Ribera, Sebastian Giebel, Herve Dombret, Oliver G. Ottmann, Dasatinib (Sprycel®) and Low Intensity Chemotherapy for First-Line Treatment In Elderly Patients with De Novo Philadelphia Positive ALL (EWALL-PH-01): Kinetic of Response, Resistance and Prognostic Significance Blood. ,vol. 116, pp. 172- 172 ,(2010) , 10.1182/BLOOD.V116.21.172.172